We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study.
- Authors
REPETTO, Federica; ROCCUZZO, Gabriele; BURZI, Lorenza; MASTORINO, Luca; DAPAVO, Paolo; QUAGLINO, Pietro; RIBERO, Simone
- Abstract
The article focuses on exploring the drug survival of anti-Interleukin-17 and Interleukin-23 agents as a switch after Adalimumab failure in Hidradenitis Suppurativa (HS). Topics include the efficacy and safety of these agents, with a pilot study conducted at the University of Turin revealing a higher discontinuation rate due to inefficacy in the anti-IL-17 group, while the anti-IL-23 group demonstrated significant improvement in clinical responses and quality of life measures.
- Subjects
HIDRADENITIS suppurativa; INTERLEUKIN-17; ADALIMUMAB; PILOT projects; DRUG accessibility
- Publication
Acta Dermato-Venereologica, 2023, Vol 103, p1
- ISSN
0001-5555
- Publication type
Article
- DOI
10.2340/actadv.v103.5278